Butanserin

DB19943ExperimentalSmall molecule

Butanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Butanserin is a serotonin receptor antagonist. Butanserin has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Alpha-1 adrenergic receptors and 5-hydroxytryptamine 2 receptor
Curator reviewed
Formula / weight: C₂₄H₂₆FN₃O₃ · 423.488 g/mol (avg)

Resolves to

Compound

UNII4I933V848GCAS87051-46-5ChEMBLCHEMBL1742433

Structure

InChIKeyMLDQSYUQSLUEPG-UHFFFAOYSA-NSMILESFC1=CC=C(C=C1)C(=O)C1CCN(CCCCN2C(=O)NC3=CC=CC=C3C2=O)CC1

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Butanserin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account